Dataset Information


ROCK Inhibition Facilitates In Vitro Expansion of Glioblastoma Stem-Like Cells.

ABSTRACT: Due to their stem-like characteristics and their resistance to existing chemo- and radiation therapies, there is a growing appreciation that cancer stem cells (CSCs) are the root cause behind cancer metastasis and recurrence. However, these cells represent a small subpopulation of cancer cells and are difficult to propagate in vitro. Glioblastoma is an extremely deadly form of brain cancer that is hypothesized to have a subpopulation of CSCs called glioblastoma stem cells (GSCs; also called brain tumor initiating cells, BTICs). We propose the use of selective Rho-kinase (ROCK) inhibitors, Y-27632 and fasudil, to promote GSC/BTIC-like cell survival and propagation in vitro. ROCK inhibitors have been implicated in suppressing apoptosis, and it was hypothesized that they would increase the number of GSC/BTIC-like cells grown in vitro and improve cloning efficiencies. Indeed, our data demonstrate that transient and continuous supplementation of non-toxic concentrations of Y-27632 and fasudil inhibited apoptosis, enhanced the cells' ability to form spheres, and increased stem cell marker expressing GSC/BTIC-like cell subpopulation. Our data indicated that pharmacological and genetic (siRNA) inhibitions of the ROCK pathway facilitates in vitro expansion of GSC/BTIC-like cells. Thus, ROCK pathway inhibition shows promise for future optimization of CSC culture media.


PROVIDER: S-EPMC4500389 | BioStudies | 2015-01-01

REPOSITORIES: biostudies

Similar Datasets

2013-01-01 | S-EPMC4434990 | BioStudies
2020-01-01 | S-EPMC7414216 | BioStudies
2010-01-01 | S-EPMC2884275 | BioStudies
2016-01-01 | S-EPMC5298928 | BioStudies
2012-01-01 | S-EPMC3314694 | BioStudies
2013-09-05 | E-GEOD-40614 | BioStudies
1000-01-01 | S-EPMC6215891 | BioStudies
2012-01-01 | S-EPMC3310724 | BioStudies
2008-01-01 | S-EPMC2377343 | BioStudies
2017-01-01 | S-EPMC5433693 | BioStudies